Back to Search
Start Over
Respiratory syncytial virus infection activates IL-13–producing group 2 innate lymphoid cells through thymic stromal lymphopoietin
- Source :
- The Journal of Allergy and Clinical Immunology
- Publication Year :
- 2016
- Publisher :
- Elsevier BV, 2016.
-
Abstract
- Background Respiratory syncytial virus (RSV) is a major health care burden with a particularly high worldwide morbidity and mortality rate among infants. Data suggest that severe RSV-associated illness is in part caused by immunopathology associated with a robust type 2 response. Objective We sought to determine the capacity of RSV infection to stimulate group 2 innate lymphoid cells (ILC2s) and the associated mechanism in a murine model. Methods Wild-type (WT) BALB/c, thymic stromal lymphopoietin receptor (TSLPR) knockout (KO), or WT mice receiving an anti-TSLP neutralizing antibody were infected with the RSV strain 01/2-20. During the first 4 to 6 days of infection, lungs were collected for evaluation of viral load, protein concentration, airway mucus, airway reactivity, or ILC2 numbers. Results were confirmed with 2 additional RSV clinical isolates, 12/11-19 and 12/12-6, with known human pathogenic potential. Results RSV induced a 3-fold increase in the number of IL-13–producing ILC2s at day 4 after infection, with a concurrent increase in total lung IL-13 levels. Both thymic stromal lymphopoietin (TSLP) and IL-33 levels were increased 12 hours after infection. TSLPR KO mice did not mount an IL-13–producing ILC2 response to RSV infection. Additionally, neutralization of TSLP significantly attenuated the RSV-induced IL-13–producing ILC2 response. TSLPR KO mice displayed reduced lung IL-13 protein levels, decreased airway mucus and reactivity, attenuated weight loss, and similar viral loads as WT mice. Both 12/11-19 and 12/12-6 similarly induced IL-13–producing ILC2s through a TSLP-dependent mechanism. Conclusion These data demonstrate that multiple pathogenic strains of RSV induce IL-13–producing ILC2 proliferation and activation through a TSLP-dependent mechanism in a murine model and suggest the potential therapeutic targeting of TSLP during severe RSV infection.<br />Graphical abstract
- Subjects :
- 0301 basic medicine
respiratory syncytial virus
PAS, Periodic acid–Schiff
0302 clinical medicine
MFI, Mean fluorescence intensity
Immunology and Allergy
Lymphocytes
Respiratory system
Lung
TSLP, Thymic stromal lymphopoietin
Plaque-forming unit
Mice, Knockout
Mice, Inbred BALB C
Interleukin-13
Group 2 innate lymphoid cells
Innate lymphoid cell
respiratory system
Viral Load
3. Good health
IL-13
PFU, Plaque-forming units
Interleukin 13
Cytokines
RSV, Respiratory syncytial virus
Female
INSPIRE, Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure
Viral load
ILC2, Group 2 innate lymphoid cell
BAL, Bronchoalveolar lavage
Thymic stromal lymphopoietin
WT, Wild-type
TSLPR, Thymic stromal lymphopoietin receptor
Immunology
Respiratory Syncytial Virus Infections
Biology
Virus
03 medical and health sciences
thymic stromal lymphopoietin
Immune Deficiencies, Infection, and Systemic Immune Disorders
ILC, Innate lymphoid cell
Animals
type 2 immunity (TH2)
KO, Knockout
Interleukin-33
Interleukin 33
Mucus
030104 developmental biology
IL-33
030215 immunology
Subjects
Details
- ISSN :
- 00916749
- Volume :
- 138
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- Journal of Allergy and Clinical Immunology
- Accession number :
- edsair.doi.dedup.....22676075c56cade28d9549cb3215a699
- Full Text :
- https://doi.org/10.1016/j.jaci.2016.01.050